journal
MENU ▼
Read by QxMD icon Read
search

Gastroenterology & Hepatology

journal
https://www.readbyqxmd.com/read/28450822/controversies-in-liver-transplantation
#1
James F Trotter
No abstract text is available yet for this article.
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28450821/key-questions-in-gastrointestinal-endoscopy-to-guide-future-research
#2
Peter D Siersema
No abstract text is available yet for this article.
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28450820/surgical-options-for-the-treatment-of-gastroesophageal-reflux-disease
#3
Tom R DeMeester
No abstract text is available yet for this article.
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28450819/reversal-of-immunogenicity-in-inflammatory-bowel-disease
#4
Shomron Ben-Horin
No abstract text is available yet for this article.
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28450818/the-role-of-regorafenib-in-hepatocellular-carcinoma
#5
Catherine T Frenette
No abstract text is available yet for this article.
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28450817/the-emerging-therapeutic-role-of-medical-foods-for-gastrointestinal-disorders
#6
Brian P Ciampa, Emmanuel Reyes Ramos, Marie Borum, David B Doman
In addition to drugs approved by the US Food and Drug Administration (FDA) that treat, cure, or mitigate disease, medical foods are a tool to help manage chronic conditions and diseases. A medical food, according to the FDA, is a food that is developed to be eaten or administered enterally under the guidance of a physician and that is meant for the specific dietary management of a condition or disease for which distinctive nutritional requirements, based upon known scientific principles, are established by medical evaluation...
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28450816/hepatitis-c-point-of-care-screening-in-retail-pharmacies-in-the-united-states
#7
Marcelo Kugelmas, Lisa D Pedicone, Idania Lio, Susan Simon, Glen Pietrandoni
Background and Aims: Approximately half of adults with hepatitis C in the United States do not know their infection status, and the majority of persons who know they are positive for hepatitis C virus (HCV) antibodies fail to receive care. We conducted a screening program in retail pharmacies and calculated the percentages of anti-HCV-positive individuals and how many subsequently entered a pathway to care. Methods: At 45 Walgreens retail pharmacies in 9 US cities, direct store advertising was used to recruit individuals for HCV antibody testing...
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28450815/evidence-based-guide-on-capsule-endoscopy-for-small-bowel-bleeding
#8
Shabana F Pasha, Jonathan A Leighton
Capsule endoscopy is the diagnostic test of choice for the evaluation of overt and occult small bowel bleeding. Its yield is higher in patients presenting with overt bleeding. The yield is also improved if the capsule is performed soon after the presentation of bleeding. Capsule endoscopy has a complementary role with cross-sectional imaging to triage patients for appropriate management, including deep enteroscopy, surgery, or, if negative, conservative management. Although capsule endoscopy is useful to detect vascular and inflammatory lesions, it appears to have a significant miss rate for solitary small bowel lesions, including tumors...
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28450814/medical-foods
#9
Gary R Lichtenstein
No abstract text is available yet for this article.
February 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28420948/nonradiation-endoscopic-ultrasound-based-endoscopic-retrograde-cholangiopancreatography
#10
Kenneth F Binmoeller
No abstract text is available yet for this article.
January 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28420947/the-use-of-fecal-calprotectin-in-inflammatory-bowel-disease
#11
Ingvar Bjarnason
No abstract text is available yet for this article.
January 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28420946/an-overview-of-transoral-incisionless-fundoplication-and-magnetic-sphincter-augmentation-for-gerd
#12
Ronnie Fass
No abstract text is available yet for this article.
January 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28420945/controversies-and-recent-developments-of-the-low-fodmap-diet
#13
Peta Hill, Jane G Muir, Peter R Gibson
The low-fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) diet is a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible short-chain carbohydrates (ie, FODMAPs) followed by reintroduction of specific FODMAPs according to tolerance. The efficacy of the elimination phase of the FODMAP diet is well established, but the success of maintaining this diet has been shown in only a few observational studies. How the efficacy of the low-FODMAP diet compares with that of other therapies has received limited attention, but recent studies have shown this diet to be comparable or superior to diets that address eating style and choice of food as well as to gut hypnotherapy...
January 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28420944/new-therapies-for-hepatitis-c-virus-infection
#14
Jennifer L Horsley-Silva, Hugo E Vargas
Approximately 350 million people worldwide are infected with hepatitis C virus (HCV), which is associated with morbidity and mortality related to cirrhosis, hepatocellular carcinoma, or liver failure. Recently, vast improvements have been made with the development of direct-acting antiviral (DAA) agents, which are all-oral, are better tolerated than interferon-based treatment, and provide a sustained virologic response in more than 90% of treated patients. This article reviews the new therapies available for HCV infection, with a focus on patients who have chronic HCV with and without compensated cirrhosis...
January 2017: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28035205/inhibition-of-interleukin-12-and-or-23-for-the-treatment-of-inflammatory-bowel-disease
#15
Sands Bruce E
No abstract text is available yet for this article.
December 2016: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28035204/esophageal-cancer-prevention
#16
K Wang Kenneth
No abstract text is available yet for this article.
December 2016: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28035203/the-possible-association-between-daa-treatment-for-hcv-infection-and-hcc-recurrence
#17
Brown Robert S
No abstract text is available yet for this article.
December 2016: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28035202/nonalcoholic-steatohepatitis-and-endpoints-in-clinical-trials
#18
William N Hannah, Dawn M Torres, Stephen A Harrison
Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of liver disease in developed countries, and the rates of NAFLD continue to rise in conjunction with the obesity pandemic. While the majority of patients with isolated steatosis generally have a benign course, a diagnosis of nonalcoholic steatohepatitis (NASH) carries a significantly higher risk for progression of disease, cirrhosis, and death. Pharmacologic therapeutic interventions in NASH have largely proven to be ineffective or unappealing due to long-term side-effect profiles, and the majority of patients cannot achieve or sustain targeted weight loss goals, necessitating an urgent need for therapeutic trials and drug development...
December 2016: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28035201/the-role-of-biosimilars-in-inflammatory-bowel-disease
#19
Sudarshan Paramsothy, Noa Krugliak Cleveland, Nada Zmeter, David T Rubin
Monoclonal antibody biologic therapies, introduced nearly 20 years ago, revolutionized the treatment of inflammatory bowel disease (IBD) and are now well established as the most effective agents available. As the first of these biologic agents starts to come off patent, biosimilar agents have emerged as alternatives to originator drugs. The unique drug development and manufacturing processes involved in the creation of biologic agents pose distinct regulatory challenges compared to generic formulations of conventional medications...
December 2016: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28035200/volumetric-laser-endomicroscopy-in-patients-with-barrett-esophagus
#20
Herbert C Wolfsen
No abstract text is available yet for this article.
November 2016: Gastroenterology & Hepatology
journal
journal
41233
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"